CF PharmTech, Inc. — Investor Relations & Filings
Filings indexed
82
across all filing types
Latest filing
2026-05-07
Regulatory Filings
Country
HK
Hong Kong
Listing
HKEX
2652
CF PharmTech, Inc. is a commercial-stage specialty pharmaceutical company specializing in the research, development, manufacturing, and commercialization of complex drug delivery systems, primarily focusing on inhalation technologies. The company develops treatments for major respiratory conditions, including asthma, Chronic Obstructive Pulmonary Disease (COPD), and allergic rhinitis. Its core product platforms encompass Inhalation Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), inhalation liquid preparations (nebulizers), and nasal sprays. The firm also leverages advanced formulation techniques, such as liposomes, to enhance drug efficacy and delivery.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| NEXT DAY DISCLOSURE RETURN | 2026-05-07 | English | |
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 | 2026-05-07 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | |
| 2025 Environmental, Social and Governance Report | 2026-04-30 | English | |
| 2025 Annual Report | 2026-04-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42895590 | NEXT DAY DISCLOSURE RETURN | 2026-05-07 | English | ||
| 42657623 | Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 | 2026-05-07 | English | ||
| 41372493 | NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | ||
| 40869494 | NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | ||
| 39090420 | 2025 Environmental, Social and Governance Report | 2026-04-30 | English | ||
| 39083797 | 2025 Annual Report | 2026-04-30 | English | ||
| 39062062 | NEXT DAY DISCLOSURE RETURN | 2026-04-30 | English | ||
| 37991777 | NEXT DAY DISCLOSURE RETURN | 2026-04-28 | English | ||
| 37399646 | NEXT DAY DISCLOSURE RETURN | 2026-04-27 | English | ||
| 36145217 | NEXT DAY DISCLOSURE RETURN | 2026-04-24 | English | ||
| 35737075 | NEXT DAY DISCLOSURE RETURN | 2026-04-23 | English | ||
| 35229316 | NEXT DAY DISCLOSURE RETURN | 2026-04-22 | English | ||
| 34743258 | NEXT DAY DISCLOSURE RETURN | 2026-04-21 | English | ||
| 34691867 | NEXT DAY DISCLOSURE RETURN | 2026-04-20 | English | ||
| 33902250 | NEXT DAY DISCLOSURE RETURN | 2026-04-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIO-FD&C CO.,LTD.
Develops active ingredients for cosmetics and pharma using …
|
251120 | KR | Manufacturing |
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
|
Biofrontera AG
Biopharmaceutical firm specializing in photodynamic therapy…
|
B8F | DE | Manufacturing |
|
Biofrontera Inc.
A biopharmaceutical company commercializing products for de…
|
BFRI | US | Manufacturing |
|
BioGaia
A healthcare and biotechnology company developing clinicall…
|
BIOG | SE | Manufacturing |
|
BIOGEN INC.
Biotechnology company developing therapies for neurological…
|
BIIB | US | Manufacturing |
|
Bio Green Med Solution, Inc.
A diversified company in the biopharmaceutical and fire saf…
|
BGMS | US | Manufacturing |
|
BIOHARVEST SCIENCES INC.
A biotech firm using a platform to grow plant cells for hea…
|
BHST | CA | Manufacturing |
|
Biohaven Ltd.
Develops therapies for neuroscience, immunology, and oncolo…
|
BHVN | VG | Manufacturing |
|
BioInvent International
Develops novel, first-in-class immuno-modulatory antibodies…
|
BINV | SE | Manufacturing |
CF PharmTech, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/50735/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=50735 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=50735 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=50735 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 50735}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CF PharmTech, Inc. (id: 50735)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.